Document Detail

Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates.
MedLine Citation:
PMID:  20514955     Owner:  NLM     Status:  MEDLINE    
We report our initial experience using Profilnine SD, a 3-Factor prothrombin complex concentrate (PCC) in combination with fresh frozen plasma and vitamin K in seven patients admitted to our neurointensive care unit with oral anticoagulation therapy-related intracranial haemorrhage over a six-month period, to achieve rapid normalisation of the international normalised ratio (INR) and allow surgical evacuation when indicated. Four patients presented with subdural haematomas while three had intracerebral haematomas. Six of seven patients had admission INR in the appropriate therapeutic range for oral anticoagulation therapy. The median dose of PCC administered was 28.5 IU/kg body weight (interquartile range 21.3 to 38.5 IU/kg). All four patients with subdural haematoma underwent surgical evacuation once INR was less than 1.5. Median time from computed tomography diagnosis to surgery was 275 minutes (range 102 to 420 minutes). The median time to INR normalisation post-PCC administration was shorter, at 85 minutes (range 50 to 420 minutes) for the four patients who survived, versus 10 hours (range 9 to 44 hours) in the three patients who died. Two of the three patients who died had haematoma increase, worsening midline shift and subfalcine herniation, leading to withdrawal of therapy. Prothrombin complex concentrates should be considered for use in the urgent reversal of INR in oral anticoagulation therapy-related intracranial haemorrhage, potentially halting haematoma expansion and expediting urgent neurosurgical intervention, although data from randomised controlled trials is still lacking. The literature supporting the use of PCC is reviewed and a protocolised emergent treatment algorithm is proposed, which may help achieve earlier consistent normalisation of the INR.
C T Chong; T W K Lew; P Kuperan; J J E Tan; H L Tan; T K Kwek
Related Documents :
19663955 - What influence do anticoagulants have on oral implant therapy? a systematic review.
9477285 - Long-term results of the simon nitinol inferior vena cava filter.
1999935 - Comparison of two levels of anticoagulant therapy in patients with substitute heart val...
10963245 - Oral anticoagulation self-management and management by a specialist anticoagulation cli...
19304125 - Waon therapy improves the prognosis of patients with chronic heart failure.
9196295 - Systematic surgical closure of patent foramen ovale in selected patients with cerebrova...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anaesthesia and intensive care     Volume:  38     ISSN:  0310-057X     ISO Abbreviation:  Anaesth Intensive Care     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-06-02     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0342017     Medline TA:  Anaesth Intensive Care     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  474-80     Citation Subset:  IM    
Department of Anaesthesiology, Tan Tock Seng Hospital, National Healthcare Group, Tan Tock Seng, Singapore.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / adverse effects*
Blood Coagulation Factors / therapeutic use*
Cerebral Hemorrhage / chemically induced,  drug therapy*
International Normalized Ratio
Middle Aged
Warfarin / adverse effects*
Reg. No./Substance:
0/Anticoagulants; 0/Blood Coagulation Factors; 37224-63-8/prothrombin complex concentrates; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tight glucose control versus intermediate glucose control: a quasi-experimental study.
Next Document:  Anti-emetic effect of midazolam added to morphine patient-controlled analgesia after total abdominal...